Home 
FOR AUTHORS General Physiology and Biophysics 2015 General Physiology and Biophysics Vol.34, No.4, p.337–352, 2015
FOR AUTHORS General Physiology and Biophysics 2015 General Physiology and Biophysics Vol.34, No.4, p.337–352, 2015
Journal info
Aims and Scope |
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
General Physiology and Biophysics Vol.34, No.4, p.337–352, 2015 |
||
| Title: The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases | ||
| Author: Alena Opattova, Martin Cente, Michal Novak, Peter Filipcik | ||
| Abstract: Impairment of “protein quality control” in neurons is associated with etiopathogenesis of neurodegenerative diseases. The worn-out products of cell metabolism should be safely eliminated via the proteasome, autophago-lysosome and exocytosis. Insufficient activity of these degradation mechanisms within neurons leads to the accumulation of toxic protein oligomers, which represent a starting material for development of neurodegenerative proteinopathy. The spectrum of CNS linked proteinopathies is particularly broad and includes Alzheimer’s disease (AD), Parkinson’s disease (PD), Lewy body dementia, Pick disease, Frontotemporal dementia, Huntington disease, Amyotrophic lateral sclerosis and many others. Although the primary events in etiopathogenesis of sporadic forms of these diseases are still unknown, it is clear that aging, in connection with decreased activity of ubiquitin proteasome system, is the most significant risk factor. In this review we discuss the pathogenic role and intracellular fate of the candidate molecules associated with onset and progression of AD and PD, the protein tau and α-synuclein in context with the function of ubiquitin proteasome system. We also discuss the possibility whether or not the strategies focused to re-establishment of neuroproteostasis via accelerated clearance of damaged proteins in proteasome could be a promising therapeutic approach for treatment of major neurodegenerative diseases. |
||
| Keywords: Alzheimer’s disease — Parkinson’s disease — Tau protein — α-synuclein — Proteasome — Heat shock proteins | ||
| Published online: 21-Sep-2015 | ||
| Year: 2015, Volume: 34, Issue: 4 | Page From: 337, Page To: 352 | |
| doi:10.4149/gpb_2015024 |
||
|
|
 download file |
|